Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Immune Design CS (IMDZ)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 69,365
  • Shares Outstanding, K 48,165
  • Annual Sales, $ 7,200 K
  • Annual Income, $ -51,860 K
  • 36-Month Beta 2.47
  • Price/Sales 30.41
  • Price/Cash Flow N/A
  • Price/Book 0.67

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate -0.29
  • Number of Estimates 5
  • High Estimate -0.25
  • Low Estimate -0.33
  • Prior Year -0.29
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.33 +8.27%
on 01/16/19
1.65 -12.73%
on 02/05/19
+0.07 (+5.11%)
since 01/15/19
3-Month
1.10 +30.91%
on 12/24/18
2.13 -32.39%
on 12/10/18
+0.02 (+1.41%)
since 11/15/18
52-Week
1.10 +30.91%
on 12/24/18
5.05 -71.49%
on 07/06/18
-2.01 (-58.26%)
since 02/15/18

Most Recent Stories

More News
Corelogic Inc Has Returned 24.8% Since SmarTrend Recommendation (CLGX)

SmarTrend identified a Downtrend for Corelogic Inc (NYSE:CLGX) on July 26th, 2018 at $51.30. In approximately 4 months, Corelogic Inc has returned 24.83% as of today's recent price of $38.56.

CTT : 9.43 (+0.86%)
EPAY : 47.96 (+1.98%)
EXAS : 88.55 (+0.49%)
WYNN : 124.51 (+0.87%)
HMSY : 32.21 (+3.01%)
GLT : 13.95 (+2.72%)
MHK : 139.21 (+0.30%)
BBW : 5.03 (+1.00%)
CDW : 94.84 (+1.05%)
COUP : 96.33 (+1.17%)
QTWO : 66.79 (-0.09%)
DENN : 17.74 (+0.91%)
MYL : 31.84 (+1.02%)
DFRG : 8.37 (-1.53%)
GCAP : 7.04 (+3.23%)
FEYE : 17.23 (-1.82%)
MXIM : 55.85 (+0.11%)
POL : 32.80 (+2.53%)
AN : 39.08 (+2.09%)
TWO : 13.89 (+0.43%)
HUBG : 45.73 (+0.75%)
AR : 9.61 (+5.95%)
RE : 216.93 (+1.35%)
NNBR : 10.35 (+0.58%)
ARE : 134.86 (+0.72%)
CVI : 42.58 (+1.16%)
CERS : 6.47 (+3.52%)
NDAQ : 87.76 (+0.69%)
ELLI : 98.90 (+0.15%)
BLDR : 13.62 (+0.74%)
EGRX : 41.90 (+3.38%)
RGLD : 87.19 (-0.32%)
PRGO : 48.95 (+0.72%)
PENN : 24.41 (-0.29%)
NTAP : 64.03 (+0.58%)
IBM : 138.03 (+1.14%)
NTRI : 43.33 (+0.32%)
BANR : 60.82 (+3.35%)
CWT : 50.93 (+0.16%)
STAA : 36.42 (+3.55%)
ATHN : 134.99 (+0.01%)
CL : 66.48 (+1.57%)
TFSL : 16.93 (+1.26%)
UFPI : 32.23 (+1.00%)
SDRL : 8.66 (+4.34%)
GOV : 6.87 (-5.50%)
HQY : 77.10 (+1.74%)
IPGP : 154.88 (+3.56%)
MINI : 36.07 (+0.08%)
CMTL : 27.20 (+0.93%)
CHD : 64.69 (+0.53%)
GPI : 61.77 (+3.90%)
HRL : 43.20 (+0.35%)
RARE : 56.65 (+2.15%)
MLI : 32.39 (+1.25%)
GPS : 25.07 (+0.60%)
CHS : 5.68 (+3.09%)
RYAM : 14.09 (+2.47%)
PBI : 7.05 (+0.86%)
NUVA : 58.59 (+0.15%)
IMDZ : 1.44 (-1.37%)
CAMP : 14.57 (+2.61%)
NOC : 286.98 (+2.27%)
AEL : 32.77 (+5.00%)
EBIX : 58.57 (+0.97%)
DISCA : 29.30 (+1.84%)
GPOR : 8.04 (+4.28%)
BGS : 26.21 (+0.77%)
TECH : 191.63 (+1.63%)
PCH : 35.47 (+1.31%)
NOV : 29.81 (+2.69%)
TECD : 104.15 (+0.97%)
DISCK : 27.65 (+1.69%)
DECK : 146.29 (+2.54%)
NOW : 234.89 (+0.37%)
MGLN : 64.82 (+2.08%)
IEX : 144.12 (+2.15%)
PTC : 91.93 (+1.03%)
AVT : 44.12 (+0.23%)
RGS : 18.36 (-0.16%)
BSFT : 54.95 (+0.09%)
FOSL : 14.88 (-2.43%)
WAL : 46.00 (+2.13%)
IVR : 15.97 (+0.19%)
ENR : 45.63 (+0.20%)
ISBC : 12.65 (+1.12%)
SHOO : 34.41 (+0.17%)
HDP : 14.68 (+1.80%)
AWK : 98.05 (+0.82%)
OMED : 0.89 (+15.58%)
LADR : 17.56 (+0.11%)
BIG : 32.27 (+0.34%)
WY : 25.54 (+0.47%)
JBLU : 17.96 (-0.66%)
GNMK : 6.31 (+3.95%)
FORM : 15.93 (+0.50%)
PFSI : 22.86 (+1.51%)
NEWM : 13.63 (+1.56%)
KFRC : 38.13 (+2.94%)
HOLX : 46.29 (+2.34%)
TMK : 83.36 (+1.87%)
AXTA : 26.68 (+0.79%)
PGEM : 21.65 (unch)
CLH : 60.04 (+1.13%)
CLI : 21.08 (+0.33%)
NRG : 42.46 (-0.35%)
CLGX : 39.74 (+0.97%)
SFLY : 46.07 (+0.37%)
ICUI : 253.28 (+1.38%)
CARA : 17.05 (+3.02%)
WTR : 35.62 (-0.08%)
NTGR : 35.60 (+0.74%)
OLED : 118.49 (+0.95%)
VNDA : 21.11 (+4.92%)
HIBB : 17.62 (-0.23%)
FFBC : 27.98 (+2.79%)
DLTR : 98.85 (+0.32%)
EQT : 18.93 (+4.01%)
OMER : 14.04 (-2.16%)
KTOS : 16.95 (unch)
SRCL : 45.56 (+1.18%)
GES : 20.45 (+0.15%)
KMX : 62.06 (+1.47%)
PLAB : 11.43 (+0.09%)
NCS : 7.67 (-1.29%)
MAR : 121.05 (+2.05%)
MRVL : 18.83 (-1.88%)
UAL : 88.31 (+0.18%)
CNK : 37.31 (+0.32%)
NATH : 74.29 (+3.61%)
TPH : 13.09 (+0.08%)
OCUL : 3.66 (-0.27%)
SKYW : 55.68 (-0.84%)
HIVE : 4.43 (+1.84%)
GAIA : 11.61 (+2.47%)
ESRX : 92.33 (-3.62%)
PHM : 27.12 (+0.78%)
EBS : 66.16 (+1.77%)
CACI : 180.06 (+1.04%)
SAVE : 61.67 (+0.41%)
EZPW : 10.02 (+1.01%)
TPX : 56.99 (+1.62%)
KLAC : 108.19 (+0.98%)
ULTA : 306.36 (+0.45%)
WWE : 87.46 (-1.59%)
ESV : 4.78 (+6.46%)
LTRPA : 16.68 (-1.18%)
DAL : 51.08 (+1.19%)
BMY : 51.67 (+1.65%)
ECL : 163.48 (+1.16%)
CHRW : 91.45 (+0.83%)
WWW : 39.58 (+2.59%)
ETH : 19.76 (+1.28%)
IART : 51.06 (+0.81%)
LE : 17.51 (+1.92%)
LH : 150.17 (+2.32%)
HZO : 19.61 (+5.49%)
MTD : 668.86 (+0.90%)
OSTK : 19.73 (+2.92%)
LDOS : 63.37 (+1.67%)
SAGE : 160.93 (+1.80%)
CIEN : 40.21 (+1.26%)
MTW : 17.47 (+3.19%)
AMC : 13.79 (+1.03%)
NDLS : 7.51 (-0.66%)
EFII : 27.59 (+0.91%)
SIVB : 246.95 (+2.73%)
MU : 41.99 (-0.57%)
DSW : 27.47 (+0.29%)
VRNT : 52.39 (+0.42%)
OII : 16.65 (+3.29%)
SAFM : 121.10 (+0.53%)
DATA : 129.34 (-0.52%)
TLYS : 11.86 (+0.42%)
TREE : 316.65 (+2.49%)
TRUP : 29.26 (+5.98%)
AMCX : 64.46 (+2.25%)
EXPD : 73.64 (-0.43%)
SUPN : 39.10 (+2.25%)
NBIX : 84.32 (-0.27%)
SAIC : 76.59 (+2.71%)
CBM : 37.68 (+5.25%)
BURL : 162.81 (+0.33%)
AMED : 136.22 (-1.81%)
EXPR : 5.29 (+1.73%)
SBH : 18.71 (+0.11%)
ATSG : 24.90 (+3.02%)
PLT : 49.62 (+3.53%)
QDEL : 65.43 (+1.76%)
NLNK : 1.53 (+3.38%)
STMP : 201.24 (+1.90%)
IPCC : 142.80 (+0.32%)
BMTC : 39.73 (+2.58%)
STML : 11.49 (+3.42%)
EGL : 29.10 (+0.24%)
LUV : 57.70 (-0.52%)
CCL : 57.25 (+0.26%)
INOV : 15.00 (+5.49%)
COTY : 11.04 (-0.36%)
MGM : 28.21 (+3.07%)
AKBA : 6.65 (+2.78%)
LGIH : 60.37 (+0.62%)
CDNS : 52.58 (+1.78%)
CRZO : 12.68 (+4.11%)
TEN : 36.25 (+6.03%)
HAIN : 17.76 (+1.78%)
Why Is Immune Design (IMDZ) Up 15.8% Since Last Earnings Report?

Immune Design (IMDZ) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

IMDZ : 1.44 (-1.37%)
Detailed Research: Economic Perspectives on NanoString Technologies, Tyson Foods, Welbilt, Immune Design, Turning Point Brands, and LGI Homes -- What Drives Growth in Today's Competitive Landscape

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of NanoString Technologies, Inc....

TPB : 38.76 (+1.02%)
WBT : 15.23 (+1.60%)
IMDZ : 1.44 (-1.37%)
LGIH : 60.37 (+0.62%)
NSTG : 23.31 (-0.26%)
TSN : 62.61 (+2.34%)
Immune Design Reports Increased Overall Response Rate and Longer Progression Free Survival of Patients with Follicular Lymphoma Treated in a Randomized Trial with a Combination Regimen of G100 and Pembrolizumab

-- Overall Response Rate (ORR) of 46% in Patients Receiving the Combination

IMDZ : 1.44 (-1.37%)
Immune Design to Present at Piper Jaffray 30th Annual Healthcare Conference

Immune Design (Nasdaq: IMDZ), an immunotherapy company focused on next-generation therapies in oncology, today announced that management will present at the Piper Jaffray 30 Annual Healthcare Conference...

IMDZ : 1.44 (-1.37%)
Immune Design (IMDZ) Posts Narrower-Than-Expected Loss in Q3

Immune Design (IMDZ) posts narrower-than-expected loss and misses revenue estimates in the third quarter of 2018. It expects to have cash to fund operations in 2021.

MRK : 79.81 (+1.10%)
IMDZ : 1.44 (-1.37%)
RHHBY : 34.0200 (+0.80%)
BMY : 51.67 (+1.65%)
Immune Design (IMDZ) Reports Q3 Loss, Lags Revenue Estimates

Immune Design (IMDZ) delivered earnings and revenue surprises of 9.38% and -37.99%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?

IMDZ : 1.44 (-1.37%)
Immune Design: 3Q Earnings Snapshot

SEATTLE (AP) _ Immune Design Corp. (IMDZ) on Tuesday reported a loss of $14 million in its third quarter.

IMDZ : 1.44 (-1.37%)
Immune Design Reports Third Quarter 2018 Financial Results and Provides Corporate Update

Conference call at 1:30 pm Pacific today

IMDZ : 1.44 (-1.37%)
Immune Design to Report Third Quarter 2018 Financial Results and Provide Corporate Update

Immune Design (Nasdaq: IMDZ), an immunotherapy company focused on next-generation therapies in oncology, today announced that it will report third quarter 2018 financial results after the close of U.S....

IMDZ : 1.44 (-1.37%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More Share

Trade IMDZ with:

Business Summary

Immune Design Corp. is a clinical-stage immunotherapy company. The Company is focused on the development of immune-based therapies based on its DCVex (TM) and GLAAS (TM) discovery platforms for cancer and other chronic conditions. Its product candidates in Phase I clinical trials comprise LV305, CMB305,...

See More

Key Turning Points

2nd Resistance Point 1.49
1st Resistance Point 1.47
Last Price 1.44
1st Support Level 1.42
2nd Support Level 1.39

See More

52-Week High 5.05
Fibonacci 61.8% 3.54
Fibonacci 50% 3.08
Fibonacci 38.2% 2.61
Last Price 1.44
52-Week Low 1.10

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar